Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is CellSource Co., Ltd. ?
1
High Management Efficiency with a high ROE of 16.26%
2
Company has very low debt and has enough cash to service the debt requirements
3
With a growth in Operating Profit of 25.85%, the company declared Very Positive results in Jan 26
- NET PROFIT(Q) At JPY 37.74 MM has Grown at 199.04%
- RAW MATERIAL COST(Y) Fallen by -8.1% (YoY)
- PRE-TAX PROFIT(Q) At JPY 57.15 MM has Grown at 54.45%
4
With ROE of 2.32%, it has a very expensive valuation with a 1.38 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -54.52%, its profits have risen by 266.5% ; the PEG ratio of the company is 0.2
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -54.52% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to CellSource Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is CellSource Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
CellSource Co., Ltd.
-100.0%
-1.85
40.07%
Japan Nikkei 225
69.64%
2.62
26.55%
Quality key factors
Factor
Value
Sales Growth (5y)
12.85%
EBIT Growth (5y)
-9.34%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
0.69
Tax Ratio
58.23%
Dividend Payout Ratio
929.37%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
115.51%
ROE (avg)
16.26%
Valuation Key Factors 
Factor
Value
P/E Ratio
60
Industry P/E
Price to Book Value
1.38
EV to EBIT
12.52
EV to EBITDA
7.46
EV to Capital Employed
2.72
EV to Sales
0.97
PEG Ratio
0.22
Dividend Yield
NA
ROCE (Latest)
21.76%
ROE (Latest)
2.32%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Movement
12What is working for the Company
NET PROFIT(Q)
At JPY 37.74 MM has Grown at 199.04%
RAW MATERIAL COST(Y)
Fallen by -8.1% (YoY
PRE-TAX PROFIT(Q)
At JPY 57.15 MM has Grown at 54.45%
-5What is not working for the Company
INTEREST(9M)
At JPY 1.04 MM has Grown at 11.9%
INVENTORY TURNOVER RATIO(HY)
Lowest at 5.87 times
NET SALES(Q)
At JPY 860.02 MM has Fallen at -7.31%
Here's what is working for CellSource Co., Ltd.
Net Profit
At JPY 37.74 MM has Grown at 199.04%
over average net sales of the previous four periods of JPY 12.62 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (JPY MM)
Pre-Tax Profit
At JPY 57.15 MM has Grown at 54.45%
over average net sales of the previous four periods of JPY 37 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JPY MM)
Raw Material Cost
Fallen by -8.1% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for CellSource Co., Ltd.
Interest
At JPY 1.04 MM has Grown at 11.9%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Net Sales
At JPY 860.02 MM has Fallen at -7.31%
over average net sales of the previous four periods of JPY 927.86 MMMOJO Watch
Near term sales trend is negative
Net Sales (JPY MM)
Inventory Turnover Ratio
Lowest at 5.87 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio






